Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Imunon is a biotechnology company developing DNA-based immunotherapies and vaccines. Its core platforms include TheraPlas for cancer treatment and PlaCCine for infectious disease vaccines, targeting solid tumors and pandemics like COVID-19. The company focuses on innovative, non-viral delivery systems to generate durable immune responses, with a pipeline emphasizing ovarian cancer immunotherapy and next-generation vaccines for emerging pathogens.
This description was generated via AI from an annual report. Updated about 1 year ago.